Clinical Trials › NCT02676739
Active, Not RecruitingPhase 2
Adderall XR and Cognitive Impairment in MS
Sponsored by Sarah Morrow
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 180
Target enrollment
May 2016
Start date
Dec 2024
Expected completion
Interventions / Treatments
Adderall XR
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
More Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.